RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer
RON和MET共表达过表达是三阴性乳腺癌患者预后不良的重要病理特征,也是酪氨酸激酶抑制剂的治疗靶点
期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2019.726
Weng, Tian-Hao; Yao, Min-Ya; Xu, Xiang-Ming; Hu, Chen-Yu; Yao, Shu-Hao; Liu, Yi-Zhi; Wu, Zhi-Gang; Tang, Tao-Ming; Fu, Pei-Fen; Wang, Ming-Hai; Yao, Hang-Ping